No Association Found Between Contrast Agents Used for MRIs and Nervous System Disorder
In this study, researchers set out to find a connection between gadolinum exposure and parkinsonism. Gadolinum-based contrast agents are used during MRIs. In the past, safety concerns have emerged about the effects these contrast agents could potentially have on the brain. Previous studies have shown neurotoxic effects when these agents were used on animals. This study looked at 246,557 patients of which 99,739 of them underwent at least one MRI with contrast. To view the results of this study, click here.
GOODMAN Oral Board Preparation Course Tumor
Nov. 1-3, 2017; Glendale, Ariz.
2017 Managing Coding and Reimbursement Challenges
Aug. 17-19, 2017; Chicago
2017 From Cranial to Spine: An Overview of Neurosurgical Topics for the Advanced Practice Provider
Aug. 30-Sept. 2, 2017; Chicago
Mayo Clinic Neuroscience and Oncology Innovation Summit 2017
Sept. 7-9, 2017; Orlando, Fla.
63rd Annual Meeting of the Western Neurological Society
Sept. 8-11, 2017; Banff, Alberta, Canada